UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number:   1-11700
 
HEMAGEN DIAGNOSTICS, INC.
 (Exact name of registrant as specified in its charter)

 
9033 Red Branch Road, Columbia, MD 21045

410-740-3198
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.01 par value per share
 (Title of each class of securities covered by this Form)

 (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

             
 
Rule 12g-4(a)(1)
  x
   
Rule 12h-3(b)(1)
  o  
 
Rule 12g-4(a)(2)
  o    
Rule 12h-3(b)(2)
  o  
       
Rule 15d-6
  x
 
             
             

Approximate number of holders of record as of the certification or notice date:

Common Stock, par value $0.01 per share – 160 holders



 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this certification/notice to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Hemagen Diagnostics, Inc.
 
 
 
       
Date:  January 30, 2013
By:
/s/ William P. Hales  
    William P. Hales  
   
President and Chief Executive Officer
 
       

 
Hemagen Diagnostics (CE) (USOTC:HMGN)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Hemagen Diagnostics (CE).
Hemagen Diagnostics (CE) (USOTC:HMGN)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Hemagen Diagnostics (CE).